Your cart is empty.
(Part 2 of 2). The effect of one's lifestyle on the epigenetic steerage of future generations, reviewed in Part I of this series, is a sobering thought. But these insights in epigenetic-based gene regulation are also opening up new possibilities in the development of novel drugs to combat, for example, cardiovascular disease, metabolic disorders, neurological disease and cancer.
We are constantly bombarded with advice on what to eat and drink, and how to exercise. Pregnant women are particularly in the spotlight, being told to avoid exposing their developing fetus to alcohol, tobacco, chemical pollutants, and stress. Who can avoid the repeated warnings about how the environment affects our health, including provoking asthma, heart disease, and metabolic disorders?
In this dizzying maze of risk and uncertainty, scientific research and the pharmaceutical industry are striving to find new ways to combat disease. Rapid progress is being made on all fronts and a relatively new field, epigenetics, is often in the spotlight.